Mangoceuticals Cash Flow Statement (2023-2026) | MGRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M-2.77M-3.40M
Depreciation and Depletion (Quarter) 0.01M0.01M0.01M0.01M0.01M0.00M252.00255.00250.00252.00255.00255.00250.00
Share-based Compensation (Quarter) 0.04M
Gains from Investment Securities (Quarter) 2.16M
Non-cash Items (Quarter) 1.16M
Cash from Operations (Quarter) -1.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.28M0.28M
Depreciation & Amortization (CF) (Quarter) 250.00
Change in Working Capital
Change in Inventory (Quarter) -0.00M-0.00M-0.00M-433.00-806.00
Change in Account Payables (Quarter) -0.11M
Change in Accured Expenses (Quarter) -0.01M
Change in Taxes (Quarter) -0.01M
Other Working Capital Changes (Quarter) -0.01M
Investing Activities
Capital Expenditures (Quarter) 0.00M
Cash from Investing Activities (Quarter) -0.00M
Financing Activities
Cash from Financing Activities (Quarter) 5.00M0.86M1.20M0.27M1.99M0.75M1.12M2.29M1.28M1.62M2.08M
Other financing activities (Quarter) 0.02M
Additional items
Exchange Rate Effect (Quarter) -433.00
Change in Cash (Quarter) -1.31M
Beginning Cash Balance (Quarter) 0.09M
Free Cash Flow (Quarter) -1.31M
Net Cash Flow (Quarter) -1.31M